Advertisement

Topics

Regulatory Harmonization Institute Company Profile

13:19 EDT 19th September 2018 | BioPortfolio

Regulatory Harmonization Institute, Inc. (RHI) is a non-profit association dedicated to global harmonization of regulatory requirements with a mission to influence the development and introduction of meaningful therapies to patients across the globe. RHI will advance global harmonization of regulatory requirements for medicines and devices intended for human use, enabling greater delivery of meaningful new therapies to all patient populations. Visit www.regharmonization.com.


News Articles [746 Associated News Articles listed on BioPortfolio]

Regulators In Mexico, Chile And Colombia Take Steps Towards Regulatory Harmonization

Medicines regulators from the Pacific Alliance have taken a step towards greater regional regulatory harmonization in a bid to make...   

US Regulatory Reads, May 2018: Embracing Harmonization, Maturity Models And More

Talk from US FDA officials last month about using the ISO 13485 quality standard to replace all or parts of...   

HIMSS 2006: Harmonization and interoperability getting more than lip service

Walking around the exhibits with my customers and fellow bloggers at HIMSS this year I found that harmonization and iteroperability were two themes that most vendors were touting. Ubiquity of networks...

#jobs #lifescience National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Health (NIH): Director, Office of Regulatory Affairs

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: National Institute of Allergy and Infectious Diseases (NIAID), National Insti...

PDA-Funded Study on Post-Approval Changes Published by The Economist Intelligence Unit

Intelligence report analyzes link between post-approval change regulations and drug shortages BETHESDA, Md. (PRWEB) June 19, 2018 PDA today announced the availability of "Medicine and vaccine sh...

China moves on to ICH GCP, despite great challenges

China in June 2017 became a member of the e International Council for Harmonization (ICH), showing the…

Older melanoma patients have better response to immune checkpoint blockade therapy

(The Wistar Institute) Patient age correlates with response to immunotherapy in melanoma and depleting regulatory T cells in young patients may have a therapeutic potential to enhance response in youn...

C-Path and CHDI launch consortium to accelerate development of Huntington's therapies

(Critical Path Institute (C-Path)) C-Path and CHDI announce the launch of the Huntington's Disease Regulatory Science Consortium (HD-RSC) to advance innovation in regulatory science methods, drug deve...

Drugs and Medications [92 Associated Drugs and Medications listed on BioPortfolio]

Sodium chloride injection usp, 0.9% [Taro Pharmaceuticals U.S.A., Inc.]

Sodium Chloride Injection USP, 0.9%

Sterile water [Hospira, Inc.]

Sterile Water For Injection, USP

Sodium chloride [Hospira, Inc.]

0.9% SODIUMCHLORIDE

Sodium chloride [General Injectables & Vaccines, Inc]

0.9% Sodium Chloride 0.9% Injection, USP Single Dose vial

Sodium chloride [Hospira, Inc.]

0.9% Sodium Chloride Injection, USP

PubMed Articles [973 Associated PubMed Articles listed on BioPortfolio]

The roadmap for harmonization: status of the International Consortium for Harmonization of Clinical Laboratory Results.

The International Consortium for Harmonization of Clinical Laboratory Results (ICHCLR) was established to fulfill recommendations identified by an international conference convened to review the avail...

Regional Approaches to Expedited Drug Development and Review: Can Regulatory Harmonization Improve Outcomes?

Drug regulatory agencies around the world have implemented programs to expedite drug development and review for promising new products for serious diseases. These programs are all intended to minimize...

Data Harmonization for a Molecularly Driven Health System.

Data commons have emerged as the best current method for enabling data aggregation across multiple projects and multiple data sources. Good data harmonization techniques are critical to maintain quali...

Cohort Harmonization and Integrative Analysis from a Biomedical Engineering Perspective.

In this review the critical parts and milestones for data harmonization, from the biomedical engineering perspective, are outlined. The need for data sharing between heterogeneous sources pave the way...

A Comparative Study of Medical Device Regulations:: US, Europe, Canada, and Taiwan.

The medical device industry is an industry dealing with multiple types of products covering a wide range of applications. As the safety and effectiveness of medical devices are vital to human health, ...

Clinical Trials [1081 Associated Clinical Trials listed on BioPortfolio]

The Differential Effects of 3 Different Immunosuppressive

The study is a laboratory investigation comparing the regulatory effects of different immunosuppressive therapies in an in vitro human MLR assay of selecting specific immunosuppressive the...

T-Regulatory Cells in Amyotrophic Lateral Sclerosis

This is an open-label pilot study to determine the safety and tolerability of infusions of autologous CD4+ CD25+ regulatory T cells with concomitant subcutaneous IL-2 injections in 4 subje...

Importance of CD4+CD25+ly in UC1. Investigation of Difference Between Blood Concentration IL 17, IL 33, Regulatory T ly in Patients With UC and Control Group

Mucosal inflammation in patients with UC is the result of immunosuppression disturbance because decreasing number of regulatory T ly and activation IL 17

Assessing the Induction of Long-term Immune Regulation Following Treatment With Lemtrada® (Alemtuzumab).

In this study the investigators wish to test the hypothesis that treatment with Lemtrada is associated with alterations in immune homeostasis in favor of multiple regulatory leukocyte popu...

Messages for Increasing Dairy Consumption

Over 35,000 Canadians, 65% of men and 72% of women aged 31-50 years fail to consume the recommended number of milk and milk product servings (≤2 servings per day). Given the wide range o...

Companies [1978 Associated Companies listed on BioPortfolio]

Regulatory Harmonization Institute, Inc.

Regulatory Harmonization Institute, Inc. (RHI) is a non-profit association dedicated to global harmonization of regulatory requirements with a mission to influence the development...

Regulatory Harmonization Institute

Regulatory Harmonization Institute, Inc. (RHI) is a non-profit association dedicated to global harmonization of regulatory requirements with a mission to influence the development...

Phase Forward

Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. Phase Forward’s products and services have been utilized in o...

Phase Forward Incorporated

Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. Phase Forward's products and services have been utilized in over 1...

Critical Path Institute (C-Path)

The Critical Path Institute (C-Path) is an independent, non-profit organization established in 2005 with public and private philanthropic support from the Arizona community, Scien...

More Information about "Regulatory Harmonization Institute" on BioPortfolio

We have published hundreds of Regulatory Harmonization Institute news stories on BioPortfolio along with dozens of Regulatory Harmonization Institute Clinical Trials and PubMed Articles about Regulatory Harmonization Institute for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Regulatory Harmonization Institute Companies in our database. You can also find out about relevant Regulatory Harmonization Institute Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record